Probably not better than placebo. Saw palmetto is the most famous prostate ingredient in the world — and the most rigorously tested. The gold-standard 2023 Cochrane review of 27 trials (4,656 men) found it produced little to no improvement in urinary symptoms or flow versus placebo. It is, however, remarkably safe. If a supplement's pitch leans entirely on saw palmetto, the evidence isn't there.
Walk down any supplement aisle in America and you'll find saw palmetto in nearly every bottle marketed to men over 50. Annual sales run in the hundreds of millions of dollars. So it's fair to ask a blunt question: does the science back the shelf space? We read the trials so you don't have to. Short version: this is one of the most interesting evidence stories in all of men's health — and it doesn't end the way the labels suggest.
What is saw palmetto, and why is it in every prostate supplement?
Serenoa repens is a small palm native to the southeastern United States. Extracts of its berries have been used for urinary complaints since at least the early 1900s.
The theory is plausible on paper: laboratory studies suggested saw palmetto might mildly inhibit 5-alpha reductase — the same enzyme targeted by the prescription drug finasteride, which converts testosterone into the prostate-growing hormone DHT (we explain that mechanism in our BPH guide). Early European trials in the 1980s–90s, many small and short, reported symptom improvements. An industry was born.
Does saw palmetto work for an enlarged prostate?
Here's the evidence timeline, honestly told:
- 1980s–1990s: dozens of small, mostly short trials, many industry-funded, report positive results. Meta-analyses of this era look favorable.
- 2006 — the STEP trial (New England Journal of Medicine): a rigorous, year-long, placebo-controlled study of 225 men finds no significant difference between saw palmetto and placebo in symptoms or flow.
- 2011 — the CAMUS trial (JAMA): the NIH funds a definitive test — 369 men, up to triple the standard dose, 72 weeks. Result: no better than placebo, even at 960 mg/day.
- 2023 — Cochrane systematic review: pooling 27 trials with 4,656 participants, the review concludes saw palmetto results in little to no difference in urinary symptoms or quality of life compared with placebo.
4,656 men
The 2023 Cochrane review — medicine's gold standard for weighing evidence — found saw palmetto alone made little to no difference versus placebo for BPH symptoms.Source: Cochrane Library, CD001423 (2023)
That is why the American Urological Association guideline does not recommend saw palmetto for BPH. One honest caveat: some researchers argue specific hexane-extracted formulations used in a few European trials may behave differently, and isolated trials of those extracts have reported benefits. It's a real scientific debate — but a thin branch to hang $40 a month on.
Why do so many men swear it works?
Three honest reasons, none of which require anyone to be lying:
- The placebo effect in BPH is enormous. In urinary-symptom trials, placebo groups routinely improve by 2–4 IPSS points — men genuinely feel better on sugar pills. Any pill taken with hope inherits that effect.
- Symptoms naturally fluctuate. BPH has good months and bad months. Men tend to start a supplement during a bad stretch — and credit the pill when the natural upswing arrives.
- Habit changes ride along. The week a man starts "taking his prostate seriously" is often the same week he cuts evening beer and coffee — changes that genuinely reduce nighttime trips on their own.
Is saw palmetto at least safe?
Yes — this part of its reputation survives the evidence. Across trials, side effects were comparable to placebo: occasionally mild stomach upset, little else. Unlike finasteride, it doesn't meaningfully suppress PSA readings at standard doses, so it's unlikely to mask cancer screening. Standard cautions apply: tell your doctor you take it, especially before surgery or if you use blood thinners.
What has better evidence than saw palmetto?
| Option | Evidence strength | Notes |
|---|---|---|
| Alpha-blockers (prescription) | Strong | Flow improves within days; standard of care |
| 5-ARI drugs (prescription) | Strong | Shrink the prostate ~20–25% over 6–12 months |
| Lifestyle changes | Moderate, free | Fluid timing, caffeine/alcohol cuts, double voiding |
| Beta-sitosterol (plant sterol) | Limited but positive | Small trials show symptom and flow improvement; the most evidence-backed plant option |
| Saw palmetto | Not better than placebo | Cochrane 2023; safe but unproven |
The practical takeaway for supplement shoppers: judge a formula by everything in it, not by the saw palmetto on the label. Ingredients like beta-sitosterol, nettle root, or nutrients addressing a real deficiency (zinc, vitamin D) each have their own — separate — evidence files. That's exactly how we graded every ingredient in our ProstaVive review: compound by compound, study by study.
Frequently asked questions
Does saw palmetto really work for an enlarged prostate?
The best available evidence says probably not better than placebo. The 2023 Cochrane review — 27 trials, 4,656 men — found little to no improvement in urinary symptoms or flow versus placebo. Earlier small trials were positive, which is why the ingredient stays popular.
Is saw palmetto safe to take?
Generally yes — side effects in trials were similar to placebo, mostly mild digestive upset. Still, tell your doctor, especially if you take blood thinners or have surgery scheduled.
How long does saw palmetto take to work?
Trials ran 4–72 weeks. Even studies favorable to saw palmetto reported benefits only after 1–3 months — and the largest high-quality trials found no meaningful benefit at any time point or dose.
What works better than saw palmetto?
Prescription alpha-blockers and 5-ARIs have far stronger evidence. Among plant compounds, beta-sitosterol has the most consistent positive data. Lifestyle changes — fluid timing, cutting caffeine and alcohol — are free and genuinely help mild symptoms.
Sources
- Cochrane Library — Serenoa repens for benign prostatic hyperplasia (2023)
- Bent S, et al., NEJM 2006 — Saw Palmetto for Benign Prostatic Hyperplasia (STEP trial)
- Barry MJ, et al., JAMA 2011 — Effect of Increasing Doses of Saw Palmetto on Lower Urinary Tract Symptoms (CAMUS trial)
- American Urological Association — BPH Clinical Guideline
- NIH National Center for Complementary and Integrative Health — Saw Palmetto: Usefulness and Safety